There’s no cure for Alzheimer’s yet, but scientists may be getting closer using an unlikely tool … cancer drugs. Researchers tested over 1,300 existing drugs to see which ones might help fight ...

Researchers recommended that regulators consider mandating head-to-head trials comparing next-in-class and against existing in-class agents when possible.

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical firm pioneering therapies delivered through the suprachoroidal ...

Discovered and developed by Sarepta Therapeutics, Elevidys is a gene therapy that won accelerated approval in June 2023 and ...

The FDA has begun accepting applications for a priority pathway designed to slas | The FDA has begun accepting applications for a priority pathway designed to slash review times to one to two months, ...

A Mayo Clinic study confirmed the accuracy of a new FDA-approved blood test for early detection of Alzheimer's disease.

Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...

It's a product commonly found on shelves at convenience stores, but Gov. Matt Meyer signed a bill on July 21 that bans it ...

The US Food and Drug Administration has issued 7 warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH), which is found in trace amounts in kratom.

Borrello is one of several lawmakers introducing a bill in Albany, mandating schools at least have these anti-choking devices ...

Tinnitus affects more than 25 million adults in the U.S., according to the American Tinnitus Association, and roughly 10% of ...